Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post-2021 Guidelines: Are Economic Barriers Finally Coming Down?

We reviewed Clostridioides difficile-positive patients discharged on fidaxomicin after local adoption of 2021 C. difficile infection (CDI) guidelines. From 14 June to 3 October 2021, 80% (12/15) had copayments of $0-$35 and 27% (4/15) required prior authorization.

The impact of the pharmacist on continuity of care during transitions of care: A systematic review.

Objectives: To evaluate programs that provide pharmacy-led continuity of care services and to assess their effectiveness in improving patient outcomes.

Data Sources: Three databases were used to conduct the article search and assess relevant articles: PubMed (Medline), Cinahl, and Web of Science.

Study Selection: Articles that included prospective measurement with defined clinical outcomes of the impact of including a pharmacist in discharge planning and continuity of care after a hospitalization were included in the review.